eLifeSystems BiologyPeer-reviewed journal article
Fibroblast Mechanotransduction Network Predicts Targets for Mechano-Adaptive Infarct Therapies
Abstract
Regional control of fibrosis after myocardial infarction is critical for maintaining structural integrity in the infarct while preventing collagen accumulation in non-infarcted areas. Cardiac fibroblasts modulate matrix turnover in response to biochemical and biomechanical cues, but the complex interactions between signaling pathways confounds efforts to develop therapies for regional scar formation. Here, we employed a logic-based ordinary differential equation model of fibroblast mechano-chemo signal transduction to predict matrix protein expression in response to canonical biochemical stimuli and mechanical tension. Functional analysis of mechano-chemo interactions showed extensive pathway crosstalk with tension amplifying, dampening, or reversing responses to biochemical stimuli. Comprehensive drug target screens in low- and high-tension contexts identified 13 mechano-adaptive therapies that promote matrix accumulation in regions where it is needed and reduce matrix levels in regions where it is not needed. Our predictions demonstrate this approachs utility for discovering context-specific mechanisms mediating fibrosis and druggable targets for spatially resolved therapies.
- Citations
- 20
- FWCI
- 2.26
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechano-Chemo Signaling Interactions Modulate Matrix Production by Cardiac Fibroblasts
J. D. Rogers, J. W. Holmes, … W. J. Richardson·bioRxiv·May 6, 2020
- Circuit to target approach defines an autocrine myofibroblast loop that drives cardiac fibrosis
Shoval Miyara, Miri Adler, … Eldad Tzahor·Cell SystemsPeer-reviewed·Feb 18, 2025
- Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts
Anders R. Nelson, Steven L. M. Christiansen, … Jeffrey J. Saucerman·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 24, 2024
- Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction
Angela C. Zeigler, Anders R. Nelson, … Jeffrey J. Saucerman·Matrix BiologyPeer-reviewed·Mar 21, 2020
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- CADHERIN-11 BLOCKADE REDUCES INFLAMMATION DRIVEN FIBROTIC REMODELING AND IMPROVES OUTCOMES AFTER MYOCARDIAL INFARCTION
Alison Schroer Vander Roest, Matthew R. Bersi, … W. David Merryman·JCI InsightPeer-reviewed·Sep 18, 2019